Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Shares Outstanding (Diluted Average) (2020 - 2025)

Rockwell Medical's Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $36.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 15.83% year-over-year to $36.0 million; the TTM value through Dec 2025 reached $36.0 million, up 15.83%, while the annual FY2025 figure was $36.0 million, 15.83% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $36.0 million in Q4 2025 per RMTI's latest filing, roughly flat from $36.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $36.0 million in Q3 2025 to a low of $8.5 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $21.8 million, with a median of $20.9 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): plummeted 88.73% in 2021, then surged 116.69% in 2022.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $8.5 million in 2021, then surged by 67.77% to $14.3 million in 2022, then soared by 63.05% to $23.3 million in 2023, then soared by 33.17% to $31.1 million in 2024, then rose by 15.83% to $36.0 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Shares Outstanding (Diluted Average) are $36.0 million (Q4 2025), $36.0 million (Q3 2025), and $34.2 million (Q2 2025).